Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Claritas Pharmaceuticals Inc
V.CLAS.H
Alternate Symbol(s):
CLAZF
Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID...
viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:CLAS.H)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(27)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Jan 05, 2022 10:39am
RE:Hopefully Stk Price Continues !!!
If they are expecting to be finish phase 1 by end of 1st quarter I don't see any way that this is going to be dragged out. Phase 1 itself will include five announcements that bump the SP. First
...more
(324)
•••
Amazigh
X
View Profile
View Bullboard History
Comment by
Amazigh
on Jan 05, 2022 7:11am
RE:Hopefully Stk Price Continues !!!
This will be the year for CLAS!!! Expect start of Phase I very very very soon
NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets
posted Nov 14, 2024 9:00am by
NurExone Biologic Inc.
-
|
“We are honored by the EMA’s recognition of ExoPTEN through the Orphan Medicinal Product Designation, which significantly advances our ability to enter the European market and offers hope to those impacted by acute spinal cord injuries,” said Dr. Lior Shaltiel, Chief Executive Officer of NurExone. “This designation, together with the ...read more
(6)
•••
HighSkies2019
X
View Profile
View Bullboard History
Post by
HighSkies2019
on Jan 04, 2022 10:44pm
Hopefully Stk Price Continues !!!
Bailey thx for a response...I hope this is not gonna drag on for another 6 to 8 wks...price jumped nicely last trade of the day...hope this year is not gonna be another year of a short or daily dream.
...more
(36)
•••
scaley
X
View Profile
View Bullboard History
Comment by
scaley
on Jan 04, 2022 9:44pm
RE:Grasping at Straws again Mr Farrell
You just don't give up eh.
(1)
•••
losingmyshirt
X
View Profile
View Bullboard History
Post by
losingmyshirt
on Jan 04, 2022 11:23am
Grasping at Straws again Mr Farrell
Useless news that is rehashed and repackaged. They have nothing and they know it. They need to put out some kind of news no matter how useless.
(27)
•••
PTBailey
X
View Profile
View Bullboard History
Comment by
PTBailey
on Jan 04, 2022 10:34am
RE:Phase 1 Start Date !!!
Haven't see a hard start date anywhere for start of Phase 1 but I am expecting Jan since they are still saying it should be completed by end of 1st Qtr. I expext a financial NR since they are
...more
(324)
•••
Amazigh
X
View Profile
View Bullboard History
Post by
Amazigh
on Jan 04, 2022 9:22am
Unofficial Analysis of the News by claritasinvestors
Prologue: We all know most of this stuff anyhow but, it seems to be a recap of everything so, the purpose seems to be to get it all out in the form of a recap right here and now for those who
...more
(324)
•••
Amazigh
X
View Profile
View Bullboard History
Post by
Amazigh
on Jan 04, 2022 8:42am
NEWS
Claritas Outlines Development Strategy for R-107 for Multiple Diseases, Disorders and Injuries SAN FRANCISCO, CA and TORONTO, ON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals,
...more
(6)
•••
HighSkies2019
X
View Profile
View Bullboard History
Post by
HighSkies2019
on Jan 04, 2022 7:46am
News Out !!!
Another nr out...no start date....just an overall repeat.....
(6)
•••
HighSkies2019
X
View Profile
View Bullboard History
Post by
HighSkies2019
on Jan 03, 2022 7:04pm
Claritas Mentioned !!!
Too bad they didn't add a sentence such as reverse in PAH as #9 did in their headline study ......would grab more attention at this time if we are gonna announce phase 1 start.... https
...more
(6)
•••
HighSkies2019
X
View Profile
View Bullboard History
Post by
HighSkies2019
on Jan 03, 2022 10:55am
Phase 1 Start Date !!!
Any idea on when phase 1 start date will really happen ?...Will we start it in Jan or is there still other nr like financials or uplisting or shares to be paid for services or Ards LOI .... Stk price
...more
(310)
•••
AngelaL
X
View Profile
View Bullboard History
Comment by
AngelaL
on Jan 02, 2022 1:42am
RE:RE: Reminder: Possible markets for our R-107
I concur entirely with your take on this. But would add that Claritas seems to be also moving towards the neonatal intensive care market. A recent PR (12/22) spoke about PPHN (persistent pulmonary
...more
(310)
•••
AngelaL
X
View Profile
View Bullboard History
Comment by
AngelaL
on Jan 01, 2022 11:14pm
RE:RE:RE:RE:RE:Upside move
Claritas raised funds recently from Obsidian. So presumably they have the resources to advance and carry out the Australian Phase 1 trial that they have described. If this is indeed the case then that
...more
(290)
•••
Moonshiner592
X
View Profile
View Bullboard History
Comment by
Moonshiner592
on Jan 01, 2022 9:07pm
RE:RE:RE:RE:Upside move
For clarity: We encountered delays due to slow release of funds from the Australian Government... then the TSE's inefficiencies made it worse... all rooted due to availability of funds... which
...more
(199)
•••
Red~One
X
View Profile
View Bullboard History
Post by
Red~One
on Jan 01, 2022 8:53pm
RE:RE:RE:RE:RE:Upside move
I didn't write the last part of that quote
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company